Certolizumab in Recurrent Implantation Failure (RIF)
Certolizumab in Recurrent Implantation Failure (RIF)
Recruiting · NCT05930613 · Registry updated 2023-12-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Certolizumab in Recurrent Implantation Failure (RIF) | Recurrent Unexplained Implantation Failure | Recruiting | Phase 3 | 2023-12-11 | NCT05930613 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 985 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Saint-Antoine Hospital - APHP | Paris | France | 2 |